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Mitochondrial optic neuropathies, that is, Leber hereditary optic neuropathy and dominant optic atrophy, selectively affect
retinal ganglion cells, causing visual loss with relatively preserved pupillary light reflex. The mammalian eye contains a light
detection system based on a subset of retinal ganglion cells containing the photopigment melanopsin. These cells give origin to
the retinohypothalamic tract and support the non-image-forming visual functions of the eye, which include the photoentrain-
ment of circadian rhythms, light-induced suppression of melatonin secretion and pupillary light reflex. We studied the integrity
of the retinohypothalamic tract in five patients with Leber hereditary optic neuropathy, in four with dominant optic atrophy and
in nine controls by testing the light-induced suppression of nocturnal melatonin secretion. This response was maintained in
optic neuropathy subjects as in controls, indicating that the retinohypothalamic tract is sufficiently preserved to drive light
information detected by melanopsin retinal ganglion cells. We then investigated the histology of post-mortem eyes from two
patients with Leber hereditary optic neuropathy and one case with dominant optic atrophy, compared with three age-matched
controls. On these retinas, melanopsin retinal ganglion cells were characterized by immunohistochemistry and their number and
distribution evaluated by a new protocol. In control retinas, we show that melanopsin retinal ganglion cells are lost with age
and are more represented in the parafoveal region. In patients, we demonstrate a relative sparing of these cells compared with
the massive loss of total retinal ganglion cells, even in the most affected areas of the retina. Our results demonstrate that
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melanopsin retinal ganglion cells resist neurodegeneration due to mitochondrial dysfunction and maintain non-image-forming
functions of the eye in these visually impaired patients. We also show that in normal human retinas, these cells are more
concentrated around the fovea and are lost with ageing. The current results provide a plausible explanation for the preservation
of pupillary light reaction despite profound visual loss in patients with mitochondrial optic neuropathy, revealing the robustness of
melanopsin retinal ganglion cells to a metabolic insult and opening the question of mechanisms that might protect these cells.
Keywords: circadian rhythms; neuro-ophthalmology; mitochondrial diseases; LHON; neuropathology
Abbreviations: DOA = dominant optic atrophy; LHON = Leber hereditary optic neuropathy; mRGCs = melanopsin-containing retinal
ganglion cells; RGCs = retinal ganglion cells
Introduction
Optic neuropathies are characterized by loss of retinal ganglion
cells (RGCs) leading to optic atrophy and blindness. Inherited
optic neuropathies due to mitochondrial dysfunction, i.e. Leber
hereditary optic neuropathy (LHON) and Kjer type dominant
optic atrophy (DOA), are known for initially affecting the parvo-
cellular RGCs (papillomacular bundle), which causes dyschroma-
topsia, loss of visual acuity, cecocentral scotomas and temporal
optic atrophy (Carelli et al., 2004). Despite loss of vision, patients
with LHON and DOA are described with visual-pupillary dissoci-
ation and relatively preserved pupillary light reaction (Wakakura
and Yokoe 1995; Bremner et al., 2001).
It is now known that, besides the image-forming function, the
eye conveys non-image-forming light information to the brain
driving the photoentrainment of circadian rhythms, masking be-
haviour, light-induced melatonin suppression and the pupillary
light reflex (Fu et al., 2005). This system operates in parallel to
the well-known image-forming pathway served by the classical
outer retinal photoreceptors, the rods and cones. The non-image-
forming system uses the newly identified photopigment melanopsin
(Opn4) expressed in a subset of intrinsically photosensitive RGCs
(Berson et al., 2002; Hattar et al., 2002). These cells project mainly
to the hypothalamic suprachiasmatic nucleus, the master circadian
clock, forming the so-called retinohypothalamic tract (Sadun et al.,
1984; Hannibal et al., 2002, 2004; Hattar et al., 2006). They also
target other areas of the brain, such as the olivary pretectal nucleus,
constituting the afferent limb of the pupillary light reflex (Hannibal
and Fahrenkrug, 2006; Hattar et al., 2006).
In humans, melanopsin-containing RGCs (mRGCs) comprise
1% of the total number of RGCs, and they are located in
both the RGC layer and the inner nuclear layer (Hannibal et al.,
2004; Dacey et al., 2005). These mRGCs have large dendritic
fields, which run predominantly in the outer sublayer of the
inner plexiform layer. The dendrites contain melanopsin and re-
spond to light by depolarization. The mRGCs also receive input
from rods and cones through the bipolar and amacrine cells, which
modulate their activity (Viney et al., 2007). There is substantial
evidence that melanopsin is a photopigment exhibiting bistability
(Mure et al., 2007), which uses an invertebrate (rhabdomeric)
signal transduction pathway (Peirson and Foster, 2006).
Melanopsin-containing RGCs are now considered the ‘circadian
photoreceptors’ and their function explains the maintenance of
photoentrainment of circadian rhythms in mouse models and
human ocular diseases characterized by loss of rods and cones
(Foster et al., 1991; Freedman et al., 1999; Hannibal et al.,
2004). Furthermore, the preservation of light-induced melatonin
suppression has been demonstrated in blind subjects, including
patients with various optic neuropathies (Czeisler et al., 1995;
Hatonen et al., 1998; Perez-Rico et al., 2009).
The present study was designed to investigate whether, in mito-
chondrial optic neuropathies such as LHON or DOA, mRGCs are
affected to an extent that would produce circadian rhythm dis-
turbances. Furthermore, we describe the characteristics and distri-
bution of mRGCs in normal human retina and in hereditary optic
neuropathies.
Materials and methods
Melatonin suppression test by light
We studied nine control subjects (mean age 34.33 8.96) and nine
subjects with molecularly confirmed mitochondrial optic neuropathy,
five LHON and four DOA (mean age 35.33 9.89). The study proto-
col was approved by the Internal Review Board ethical committee and
written informed consent was obtained from both controls and pa-
tients. All the subjects enrolled in the study reported no history of
working night shifts nor did they travel more than two time zones
within 1 month prior to the test. The subjects had not taken drugs
interfering with nocturnal melatonin synthesis (i.e. beta-blockers,
alpha-blockers, non-steroidal anti-inflammatory drugs, serotonin reup-
take inhibitors, neuroleptics, antiepileptics and monoaminoxidase in-
hibitors). All control subjects had normal vision. The hereditary optic
neuropathy subjects had an extensive ophthalmologic evaluation
including, as an objective indicator of their clinical severity, optical
coherence tomography (StratusOCT, software version 3.0; Carl Zeiss
Meditec Inc., Dublin, CA) measurements of retinal nerve fibre
layer thickness (RNFL 3.4 protocol). To characterize the chronotype,
psychiatric disturbances, sleep disturbances and quality of life, all sub-
jects filled out self-administered questionnaires (Horne-O¨stberg
Morningness–Eveningness Scale; Pittsburgh Sleep quality index, Zung
depression and anxiety scales, SF-36 quality of life scale, Epworth
Sleepiness Scale and Berlin Questionnaire). This study was carried
out between December 2007 and May 2008.
The study protocol consisted of one baseline night and one light
exposure night (Supplementary Fig. 1). A sleep diary was used the
week prior to the test to monitor the sleep–wake cycle. Subjects
were asked to refrain from alcohol 48 h prior to each test and not
drink coffee or eat bananas, cheese or chocolate 12 h before the
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test. For the baseline night, all subjects were lying down in the bed in
a dim light (55 lux) room and were blindfolded from 10 pm to 8 am.
The same setting was used for the melatonin suppression night except
for the exposure to monochromatic (470 nm) blue light from 1:30 to
3:30 am (Supplementary Fig. 1). The light was generated by two
vertical lamps (38 LEDs) that projected light onto the ceiling (Sivra,
Guzzini, Italy). The ceiling surface that reflected this light was
100 cm150 cm and positioned 2 m from the subject eyes
(Supplementary Fig. 1). Irradiance at the level of the subjects’ corneas
was 58 mW/cm2, as detected by spectroradiometric assessment. Blood
samples were collected each hour from 00:30 to 3:30 am and mela-
tonin plasma concentrations evaluated by radioimmunoassay
(Melatonin Direct RIA-KIPL3300; Pantec-Biosource Europe S.A.). The
minimum detection limit of the assay was 2 pg/ml. The magnitude of
melatonin suppression was assessed by two previously reported
control-adjusted scores: melatonin suppression score and suppression
rate (Brainard et al., 2001; Hebert et al., 2002). We also computed
the percentage difference between melatonin plasma levels before and
after light exposure in the melatonin suppression night (absolute per-
centage difference) (for details see Supplementary material).
Immunohistochemical analysis of
melanopsin-containing retinal
ganglion cells in human retinas
Eyes with optic nerves were obtained post-mortem from two male
subjects with LHON (59- and 52-year-old) and from one male subject
with DOA (87-year-old). Eyes were also acquired from an eye tissue
bank (Lions Eye Bank of Oregon, USA) for age- and sex-matched
controls (males; 58, 54 and 85 years old, respectively). We excluded
tissues from subjects with a history of diabetes and neurological dis-
orders. All tissues were initially immersion-fixed in neutral buffered
formalin. Eyes and nerves were oriented for superior and temporal
zones with tissue ink. The eyes were dissected horizontally at the
meridian producing two collotes containing the entire retina (nasal
and temporal), at that level bisecting the papillomacular bundle.
Tissue from the superior half was embedded in paraffin and serially
sectioned at 5 mm. Sections were immunostained for melanopsin
[rabbit anti-melanopsin, code no. 5J68, characterized in detail by
Hannibal et al. (2004)] using an indirect immunoperoxidase technique
with diaminobenzidine as the substrate/chromogen or immunofluores-
cence (Hannibal et al., 2004). Immunostaining was performed on
seven to ten serial sections to define the extent of each single
mRGC and establish the counting criteria for subsequent quantitative
analysis. To this end, mRGCs were then identified and manually
counted by two independent observers on five to six sequential
slides originating from every fifth section. Melanopsin stained RGCs
were further confirmed and photographed at high magnification by
the two observers.
We counted each mRGC that demonstrated a significant amount of
stain indicating a complete soma and having the nucleus and some-
times the nucleolus visible. In these latter cases, the cells were con-
sidered to be cut approximately through their middle. Furthermore,
the length of each retina section was measured on serial photographs
overlapping on the borders, covering the entire retina available.
Counting of mRGCs allowed for calculation of their area density
across the posterior retina in the nasal/temporal axis. This retinal
cross-section, 5 mm in thickness, included cells cut approximately
through their middle, with the nucleus visible. Hence, the sampling
area around each section would be large, 2-fold (one for each side)
the mean radius of the mRGC (5 mm) plus the thickness of the retinal
section (5 mm), so that the density has been calculated dividing the
number of mRGCs for the total sampling area (length of the retinal
cross-sections multiplied by 15mm). The total retinal area density of
mRGCs in each eye was calculated assuming an average total surface
in human retina of 1040 mm2 and an even superior/inferior distribu-
tion of mRGCs (Curcio and Allen, 1990).
Total RGC numbers were calculated through measurements in the
optic nerve and based on the assumption that one RGC produces one
axon that passes through the optic nerve. Optic nerve cross-sections
were previously analysed by axonal morphometry for normal subjects
at different ages with paraphenylenediamine-based image analysis
(Tenhula et al., 1992). Thus, to obtain the ratio of mRGCs on the
total number of RGCs for the control eyes, we considered an average
of 1 200 000 RGCs per retina, as previously reported by our laboratory
(Johnson et al., 1987). For the two LHON subjects, the total number
of RGCs was measured by counting the axons in the optic nerve
cross-sections, using similar paraphenylenediamine-based manual
count (see next section). For the DOA subject, the counting of
axons in the only optic nerve cross-section available was performed
by identifying axons using an immunostaining for neurofilaments in
sections cut from paraffin-embedded blocks, not having plastic-
embedded tissue available.
Each retinal section was divided into two hemiretinas (nasal and
temporal) assuming the macula as the zero point centred 15 temporal
to the optic disc. Position of each mRGC, either in the inner nuclear
layer or in the RGC layer, was reported in grades considering its dis-
tance from zero on a proportional scale in which the maximum length
was 60 and 90 for temporal and nasal hemiretina, respectively.
For statistical analysis (see below), we also calculated the number
of mRGCs in each 20 sector, starting from the parafoveal sector
(10 nasally and 10 temporally to the macula).
Morphometric assessment in
optic nerves
Optic nerves were cut into cross-sections 2 mm thick and 3 mm pos-
terior to the globe. Orientation was established by razor nicks and the
specimens were processed for paraffin and plastic blocks. The paraffin
tissue blocks (DOA subject) were cut with a microtome at 5 mm,
stained with haematoxylin and eosin and immunostained using an in-
direct method with horseradish peroxidase and diaminobenzidine as
substrate/chromogen for neurofilaments. Semi-thin sections were cut
on an ultramicrotome at 1 mm from plastic-embedded tissues (LHON
subjects) and stained with paraphenylenediamine for light microscopic
examination of myelin profiles. All light microscopic photos of eyes and
nerves were acquired with a Spot II digital camera (Diagnostic
Instruments Inc.) and digitally saved on a computer.
The axonal count in the optic nerves from the two LHON and DOA
subjects was manually performed on images acquired at 1000 with a
100 oil immersion lens. The optic nerve cross-section profiles were
divided into five regions, each with a different axonal density, to
account for the non-homogeneous distribution of axonal loss (for
details on the sampling method applied, see Methods section in
Supplementary material). Each image was reviewed by two independ-
ent observers. The counts for the five regions were summed to obtain
the total axon count for each optic nerve.
Statistical analysis
Statistical analysis was performed using Statistical Package for Social
Sciences (SPSS ver.12.0, Chicago, IL). Light-induced suppression of
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melatonin secretion was evaluated by means of a paired-sample t-test
comparing plasma melatonin levels at the corresponding time point in
the baseline and light suppression nights. Differences between the
groups in melatonin plasma levels and optical coherence tomography
measurements were assessed by one-way ANOVA considering signifi-
cant a P-value lower than 0.05. For self-administered questionnaires, a
non-parametric analysis (Kruskal–Wallis) was performed. Correlation
between melatonin suppression scores and clinical variables was
assessed by using Pearson coefficient for questionnaires and
Spearman analysis for ophthalmologic data.
To evaluate the homogeneity of mRGC distribution throughout the
retina, we performed a one-way ANOVA, comparing their mean
number between different 20 retina sectors for each group
(see Figs 2 and 4 as well as Supplementary material). Moreover, by
means of parametric statistic, we compared the number of mRGCs in
controls and optic neuropathy subjects, both in the entire retina and
for each equivalent sector.
Results
Melatonin suppression test by light
Exposure to light during night suppresses melatonin secretion
(Klein and Weller, 1972) and this response is conveyed by the
mRGC–retinohypothalamic tract pathway (Brainard et al.,
2001). A few studies investigated this response in blind human
subjects showing that it may be preserved (Czeisler et al., 1995;
Hatonen et al., 1998; Perez-Rico et al., 2009). However, the blind
subjects investigated were not homogeneous for pathology and
only a few were affected by optic neuropathy of variable aeti-
ology. We aimed to explore the light-induced suppression of
melatonin secretion in a homogeneous group of nine patients af-
fected by mitochondrial optic neuropathy (five LHON and four
DOA), which selectively affects the RGCs, compared with nine
sex- and age-matched controls. Demographic, genetic and
ophthalmologic data of patients with optic neuropathy are pro-
vided in Table 1. The results of the melatonin suppression tests for
controls and optic neuropathy subjects are shown in Fig. 1.
All optic neuropathy subjects had poor vision but a relatively
preserved pupillary light reflex. Mean visual acuity and standard
deviation of the better eye was 0.09 0.1 for LHON subjects and
0.2 0.1 for DOA subjects, with no significant differences. Thus,
the two mitochondrial optic neuropathies were grouped together
for further analysis. All optic neuropathy subjects showed severe
optic atrophy on fundus examination. Optical coherence tomog-
raphy evaluation revealed a substantial reduction of retinal nerve
fibre layer thickness in both optic neuropathies (Fig. 1A and
Supplementary Table 1). Self-administered questionnaires assess-
ing quality of life, sleep and mood disturbances did not reveal
significant differences between controls and optic neuropathy sub-
jects except for items A (physical functioning) and C (bodily pain)
of Short Form 36-Item quality of life scale (raw data for controls
and optic neuropathy subjects are provided in Supplementary
Tables 2 and 3).
The study design, described in the Methods section, included a
basal night and a test night (Supplementary Fig. 1). All subjects
showed a physiological increase of melatonin plasma levels during
the baseline night, but the melatonin plasma levels were higher
(P50.05) in optic neuropathy subjects than controls (Fig. 1B).
A significant suppression of melatonin plasma levels induced by
blue light was observed in both control (P50.0001) and optic
neuropathy subjects (P50.005) (Fig. 1B). Individual profiles
of baseline and light suppression nights are provided in
Supplementary Figs 2 and 3. Furthermore, we compared the re-
sults of the melatonin suppression test in LHON and DOA subjects
and found no significant differences (data not shown). Specifically,
the magnitude of suppression was not statistically different be-
tween groups, for each of the three indices considered: control
adjusted melatonin suppression score (P= 0.9), suppression rate
(P= 0.5) and absolute percentage difference (P= 0.64) (Fig. 1C).
We failed to identify any correlation between melatonin suppres-
sion scores and the ophthalmologic outcome measurements
(i.e. retinal nerve fibre layer thickness by optical coherence tom-
ography and visual acuity). A positive correlation was detected
only between the absolute percentage difference score and the
Pittsburgh sleep quality index (P= 0.019) in both controls and
optic neuropathy subjects.
These results suggest that light suppression of melatonin secre-
tion is maintained in visually impaired subjects with mitochondrial
optic neuropathy, indicating that the mRGC-retinohypothalamic
tract pathway is essentially spared. This observation is in agree-
ment with the relative preservation of the pupillary light reflex, as
assessed at clinical exam in the patients with LHON and DOA.
Table 1 Demographic, genetic and ophthalmologic data
ID Sex Age Mutation Onset Visual acuity
Oculus
destrum
Oculus
sinistrum
L1 M 32 11778/ND4 mtDNA (homoplasmic) 26 0.01 0.02
L2 M 31 11778/ND4 mtDNA (homoplasmic) 15 0.01 0.0125
L3 F 52 3460/ND1 mtDNA (homoplasmic) 12 0.05 0.02
L4 M 28 14484/ND6 mtDNA (heteroplasmic) 17 0.32 0.16
L5 M 26 3460/ND1 mtDNA (homoplasmic) 17 0.04 0.02
D1 F 22 Mut OPA1 (frame-shift/stop-codon) Exon 27; 2708-2711del (TTAG) (heterozygous) 6 0.16 0.16
D2 M 41 Mut OPA1 (splicing error) Exon 9; 984 + 3A4T (heterozygous) 1 0.05 0.05
D3 F 41 Mut OPA1 (missense) Exon 27; 2729T4A (Val910Asp) (heterozygous) 1 0.2 0.2
D4 M 45 Mut OPA1 (frame-shift/stop-codon) Exon 27; 2708-2711del (TTAG) (heterozygous) 510 0.32 0.4
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Characterization of
melanopsin-containing retinal
ganglion cells in human retinas
Despite the plethora of histological studies investigating mRGCs in
different animal species, only a few have characterized this cellular
system in human retinas (Hannibal et al., 2004; Dacey et al.,
2005; Vugler et al., 2007). To fill this gap, we investigated
three pairs of eyes from normal donor subjects: a 58-year-old
(Control 1), a 54-year-old (Control 2) and an 85-year-old
(Control 3) male subject. The oldest subject was investigated to
take into account the ageing process; in fact, previous studies
from our group showed that after the age of 60 there is a pro-
gressive loss of axons that corresponds to a decrease of RGCs
(Johnson et al., 1987).
Immunohistochemistry, using human melanopsin antibodies on
sagittal sections of the retina, revealed the presence of mRGCs
and their dendrites with the cell bodies either in the RGC layer
Figure 1 (A) Retinal nerve fibre layer thickness evaluated by optical coherence tomography in optic neuropathy and control subjects.
Average retinal nerve fibre layer (RNFL) thicknesses of temporal, superior, nasal and inferior quadrants are shown for control, LHON and
DOA subjects. Retinal nerve fibre layer thickness was significantly lower in optic neuropathy subjects compared with controls in each
quadrant. There were no statistical differences between LHON and DOA subjects except for superior retinal nerve fibre layer thickness,
which was significantly lower in LHON subjects (P= 0.037). The average retinal nerve fibre layer thickness was 97.3 mm  8.4 in controls,
52 mm  9 in LHON and 59.3mm  5.8 in DOA subjects. (B) Melatonin suppression test results in control and optic neuropathy subjects.
Box plots of melatonin plasma levels at the four sampling times (00:30, 01:30, 02:30, 03:30 am) are shown for the baseline (dark grey)
and light suppression (light grey) nights in control (CTRLs; left panel) and optic neuropathy (right panel) subjects. In the control group, a
significant difference in melatonin plasma levels between the baseline and the test night was evident for the third (P= 0.000008) and
fourth samples (P= 0.00015); this difference was also evident in optic neuropathy subjects for the third (P= 0.0018) and fourth
(P= 0.0046) samples. Asterisks indicate these significant differences. (C) Melatonin suppression scores for controls and optic neuropathy
subjects. Box plots of control-adjusted melatonin suppression score (caMSS), suppression rate and absolute difference (%) scores are
shown for control (dark grey) and optic neuropathy (ON; light grey) subjects in the left, middle and right panels, respectively. No statistical
differences were evident between groups, demonstrating similar magnitude of light-induced melatonin suppression.
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or in the inner nuclear layer, as previously reported (Fig. 2A)
(Hannibal et al., 2004). The mRGCs were characterized by
having a large cell body (15–20 mm) with a centrally located nu-
cleus. The pigment was located primarily in the membrane of the
soma and in the dendrites. The dendrites were located in two
different layers. The majority of dendrites were found at the
border of the inner nuclear layer known as the OFF layer of the
inner plexiform layer. The dendrites were also located close to
RGC layer, known as the ON layer of the inner plexiform layer.
Occasionally, delicate thin axons were also identifiable by their
melanopsin brown staining as they ran from the RGC soma into
and along the retinal nerve fibre layer (Fig. 2A).
To evaluate the ratio of mRGCs relative to the total number of
RGCs in human retinas, we assumed that the number of RGCs is
equivalent to the number of axons counted in optic nerve
cross-sections. Thus, we used 1 200 000 as the average number
of RGCs in controls younger than 60 years of age, as reflected by
optic nerve axonal counts previously carried out in our laboratory
(Tenhula et al., 1992). To evaluate the loss of axons with ageing,
we manually counted them in an optic nerve cross-section from
the 85-year-old subject, obtaining an estimate of 978 000 axons.
To obtain the mRGC density relative to retinal surface, we
assumed that mRGCs are homogeneous in distribution over the
1040 mm2 established total retinal surface (Curcio and Allen,
1990). Thus, quantitative evaluation by manual counting of
mRGCs resulted in a mean density of 18 cells/mm2 for Control
1 and 13 cells/mm2 for Control 2, whereas the mean density was
8 cells/mm2 for Control 3 (Supplementary Table 4). Finally, the
percentage of mRGCs, over the total number of RGCs, was
1.5% for Control 1, 1.1% for Control 2 and 0.9% for the
oldest, Control 3 (Fig. 2B). We next evaluated how many of the
mRGCs were located in the RGC layer and in the inner nuclear
layer, obtaining comparable numbers in the two layers
(Supplementary Fig. 4 and Table 4). Overall, these data indicate
that in humans, the number of mRGCs in the RGC layer is about
equal to those located in the inner nuclear layer, at odds with the
previous estimations in rodents (Baver et al., 2008).
A further objective of our study was to describe the distribution
of mRGCs on the two hemiretinas, nasal and temporal, relative
to the fovea (central retina) by using intervals of 20 (for recon-
struction of the retina, see the ‘Methods’ section and
Supplementary Fig. 5). The 20 range was chosen in order to
have a larger sample size per angle and for isolated comparison
of the parafoveal and peripapillary zones. The overall estimation
for the two younger controls showed a higher number of mRGCs
in the parafoveal region centred 15 temporal to the optic disc
(Fig. 2C, left panel), which was close to significance when com-
pared with the far temporal end (P= 0.052). A second enrichment
in mRGCs was observed at the far end of the nasal hemiretina.
Comparing these results with those obtained in the oldest subject,
we observed a general loss of mRGCs in the latter except for
those in the parafoveal region (Fig. 2C, right panel), which was
significantly different from the remaining retinal sectors (P= 0.05)
except for the far nasal end. Thus, these results indicate a general
loss of mRGCs that is age related, which spares the parafoveal
region. This overall decrease of mRGCs in the oldest subject par-
allels the previously described reduction of axons (and RGCs) after
the age of 60 in humans (Johnson et al., 1987) and is similar to
previous descriptions of mRGC loss with ageing in animals (Semo
et al., 2003).
Our characterization of mRGCs in normal and ageing humans
showed that these cells constitute 1% of total RGCs, are roughly
equally distributed in the RGC layer and the inner nuclear layer
and are more represented in the central retina. The mRGCs, like
other RGCs, become less numerous with age. These results cor-
roborate previous reports using flat-mounted retinas (Hannibal
et al., 2004; Dacey et al., 2005), validating our methodology of
using serial retinal sections sagittal to the optic nerve head and
with temporal-nasal orientation.
Analysis of melanopsin-containing
retinal ganglion cells in mitochondrial
optic neuropathy patients
To explore directly the histopathology of mRGCs in mitochondrial
optic neuropathies, we studied retinal specimens collected at aut-
opsy from patients with LHON and DOA, comparing them with
control subjects. We had available four eyes from two LHON sub-
jects, one eye from a DOA individual, and the above described six
eyes from three age- and sex-matched controls for comparison.
The two LHON subjects were brothers, included in a prospective
clinical study, thus systematically evaluated prior to death (Sadun
et al., 2003). They both belonged to a large Brazilian pedigree of
Italian maternal ancestry carrying the 11778/ND4 mutation in
mitochondrial DNA (Carelli et al., 2006). However, the severity
of optic neuropathy differed markedly in these two subjects. The
59-year-old man had a late-onset and mild form of LHON, where-
as his 52-year-old brother had a classical LHON with young–adult
onset and severe optic atrophy. The neuro-ophthalmologic
evaluation of these two LHON subjects is summarized in Table 2
and Figs 3A and B.
The patient with mild LHON suffered visual loss at 51 years of
age precipitated by abuse of tobacco and alcohol; he remained
mildly affected until his death. His fundus examination revealed
mild optic neuropathy with temporal optic atrophy (Fig. 3A, upper
panels). Post-mortem evaluation of the optic nerves revealed a
similar sectorial loss of axons (Fig. 3A, middle panels).
Examination at higher magnification documented the remaining
axonal density as high nasally, intermediate in the transition
zone and low temporally (Fig. 3A, lower panels).
The patient with severe LHON suffered visual loss at 27 years of
age and remained stable for 25 years before he died. Fundus
examination showed complete optic atrophy bilaterally (Fig. 3B,
upper panels). Post-mortem evaluation of the optic nerves
revealed reduced cross-sectional profiles with massive axonal loss
throughout except for some sparing nasally (Fig. 3B, middle
panels). Examination at higher magnification documented the
remaining axonal density as depleted nasally, low in the transition
zone and very low temporally (Fig. 3B, lower panels).
The patient with DOA was an 87-year-old man, belonging to a
family of 152 members reported by Kjer in the seminal description
of DOA (Kjer, 1959). The frame-shift inducing 2826delT
(p.V942fsX967) mutation in exon 28 of the OPA1 gene was
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Figure 2 (A) Melanopsin retinal ganglion cells in control retinas. Upper line: (left) one example of a brown-stained mRGC located in the
RGC layer is shown including the large cell body with the nucleus and a dendrite running at the border of the inner nuclear layer; (middle)
a brown-stained mRGC located in the inner nuclear layer is depicted; (right) the peripheral staining of melanopsin under the plasma
membrane is evident in this mRGC located in the RGC layer. Lower line: (left) one example of a long dendrite running close to the RGC
layer is shown; (right) one example of a thin axon filled with brown-stained melanopsin in the retinal nerve fibre layer is depicted (scale bar
represents 20 mm). (B) Ratio of mRGCs relative to the total number of RGCs in control retinas. The ratio of mRGCs relative to the total
number of RGCs is shown for Control 1 (left), Control 2 (middle) and Control 3 (right), respectively. (C) Retinal distribution of mRGCs in
control subjects. Distributions of mRGCs in four eyes from averaged Controls 1 and 2 (left) and in the two eyes from Control 3 (right) are
shown. The mean number of mRGCs ( SD) is reported for each 20 sector of the temporal and nasal hemiretinas, centred to the fovea.
Mean number of mRGCs in parafoveal sector (t10n10) is greater in the two younger controls, being close to statistical significance with
respect to the far temporal hemiretina (P= 0.052). In the oldest, Control 3, the number of mRGCs in parafoveal sector (t10n10) is also
greater and significantly different (P= 0.05) with respect to all sectors except for n50n70 and n70n90 (t10n10 versus:
t60t50 P= 0.01; t50t30 P= 0.024; t30t10 P= 0.024; n10n30 P= 0.024; n30n50 P= 0.015). RNFL = retinal nerve fibre
layer; RGCL = retinal ganglion cell layer; IPL = inner plexiform layer; INL = inner nuclear layer.
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recently described (Thiselton et al., 2002). This patient complained
of decreased vision and visual difficulties in poor light and in
colour perception. His visual acuity was 0.1 in oculus destrum
(right eye) and counting fingers in oculus sinistrum (left eye).
Fundus examination revealed diffuse optic atrophy (Fig. 3C).
The histopathology of this subject’s eyes has been previously
reported (Kjer et al., 1983). We had available the left optic
nerve for this study, and a severe loss of axons affected most
of the cross-section, similar to the findings in the LHON subjects
(Fig. 3C).
Immunohistochemistry with melanopsin antibodies on the ret-
inas from these LHON and DOA subjects revealed the presence
of mRGCs and of their dendrites similar to the control subjects,
notwithstanding the severe loss of total RGCs (Fig. 4A). In terms
of gross morphology, dimension and dendritic branching pattern,
these mRGCs did not differ from those described in the control
retinas.
The residual axons were counted manually in the optic nerve
cross-sections from the optic neuropathy cases. This count re-
vealed an average between the two eyes of 300 000 axons
for the mild LHON (74% loss as compared with 1 200 000
axons in normal eyes) and 22 500 for the severe LHON (98%
loss) and 15 000 for the DOA (94% loss as compared with
977 851 axons counted for the age-matched control eye)
(Fig. 4B, left panel). Quantitative evaluation by manual counting
of mRGCs resulted in a density of 9 cells/mm2 for mild LHON, 8
cells/mm2 for severe LHON and 7 cells/mm2 for the DOA subject
(Supplementary Table 4). These counts were approximately half of
those obtained for the two younger controls (Fig. 4B, middle
panel).
For LHON subjects, the total RGC number was based on direct
axonal counts in the corresponding optic nerve cross-sections, as
described above. Thus, the percentage of mRGCs was increased
as the total number of RGCs decreased. This percentage was
3.1% for mild LHON and 38.5% for severe LHON compared
with an average of 1.3% for the two age-matched controls
(Fig. 4B, right panel). To match the age of the DOA subject we
used the 85-year-old Control 3. Thus, the percentage of mRGCs,
compared with the total number of RGCs, was 48.6% for the
DOA subject and 0.9% for Control 3 (Fig. 4B, right panel). The
mRGCs were approximately equally distributed in the RGC layer
and inner nuclear layer in the optic neuropathy cases, similar to
control subjects, indicating that the relative distribution of mRGCs
in RGC layer and inner nuclear layer among both control and
optic neuropathy subjects was not different (see Supplementary
Fig. 4 and Table 4).
The analysis of mRGC distribution for nasal and temporal hemi-
retinas in the two LHON subjects shows that despite an overall
absolute loss of mRGCs, more remain in the parafoveal region
(Fig. 4C, left panel). This result was significantly different from
sectors t60t50, t50t30 and n50n70 (P= 0.002, 0.04
and 0.008, respectively). The retina from the patient with DOA
had an essentially uniform distribution of mRGCs, not showing the
parafoveal enrichment (Fig. 4C, right panel). A sector-by-sector
comparison of the optic neuropathy subjects with the correspond-
ing age-matched controls failed to reveal significant differences.
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The overall comparison of all 11 eyes from controls and optic
neuropathy subjects investigated is depicted in Fig. 4D. This dem-
onstrates clearly the non-uniform distribution of mRGCs in human
retinas, with a significant enrichment in the parafoveal region that
is maintained despite neurodegeneration in LHON and ageing.
The single retina from the DOA case, exposed to the combination
of both neurodegeneration and ageing, showed a flat distribution
of mRGCs.
Discussion
We investigated a class of optic neuropathies characterized by
selective and massive loss of RGCs and preservation of the
pupillary light reflex (Wakakura and Yokoe 1995; Bremner
et al., 2001; Carelli et al., 2004). In these optic neuropathies,
RGC loss is due to a neurodegenerative process caused by mito-
chondrial dysfunction, and in the present study we document the
resistance of mRGCs to this pathogenic mechanism. Nine patients
with LHON or DOA maintained light-induced suppression of
melatonin nocturnal secretion comparable to nine control subjects,
despite their severe visual loss and optic atrophy. We examined 11
retinas from optic neuropathy subjects and age-/sex-matched con-
trols and we demonstrated the relative preservation of mRGCs
compared with total RGC loss in affected subjects. Furthermore,
we characterized the mRGC system in human retinas, showing
that these photoreceptors are more concentrated around the
macula and undergo a reduction in numbers with ageing, possibly
Figure 3 (A) Ocular findings in the mild LHON case (mLHON). Upper line, on the left the oculus destrum (OD) fundus with moderate
temporal pallor of the optic disc is shown; on the right the oculus sinistrum (OS) fundus is characterized by a more severe sectorial
temporal pallor of the optic disc. Middle line, on the left oculus destrum optic nerve cross-section shows severe depletion of axonal bundles
involving the temporal fibres; on the right oculus sinistrum optic nerve cross-section reveals more extended depletion of axonal bundles
involving the temporal fibres (scale bar represents 1 mm). Lower line, on the left, high-magnification images of nasal axonal bundles
demonstrate high, virtually normal axonal density, whereas in the middle the transition zone is characterized by intermediate axonal
density, and on the right, the temporal sector shows low axonal density (scale bar represents 20 mm). Axons are identified as myelin
profiles stained by paraphenylenediamine on semithin sections cut from plastic-embedded tissue (see ‘Materials and methods’ section).
(B) Ocular findings in the severe optic atrophy case (sLHON). Upper line, funduscopic images show complete optic atrophy on both oculus
destrum (left) and oculus sinistrum (right). Middle line, oculus destrum (left) and oculus sinistrum (right) optic nerve cross-sections reveal
diffuse and severe depletion of axonal bundles involving the entire optic nerve with some preservation of the nasal bundles (scale bar
represents 1 mm). Lower line, high-magnification images of nasal axonal bundles demonstrate depleted axonal density (left), whereas the
transition zone reveals low axonal density (middle) and the temporal sector shows very low axonal density (scale bar represents 20 mm).
Axons are identified as myelin profiles stained by paraphenylenediamine on semithin sections cut from plastic-embedded tissue (see
‘Materials and methods’ section). (C) Ocular findings in the DOA case. Upper line, funduscopic images show complete optic atrophy on
both oculus destrum (left) and oculus sinistrum (right). Middle line, OS optic nerve cross-section shows diffuse and very severe depletion
of axonal bundles involving the entire optic nerve (scale bar represents 1 mm). Lower line, images at increasing magnification show the
axonal depletion of spared bundles in the central area of the optic nerve cross-section (scale bars represent, respectively, 100, 50 and
20 mm). Axons are identified as axoplasm immunostained for neurofilaments on sections cut from paraffin tissue blocks (see ‘Materials and
methods’ section).
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Figure 4 (A) Melanopsin cells in control and optic neuropathy retinas. In the upper line, examples of brown-stained mRGCs located both
in the RGC layer and in the inner nuclear layer for all three controls are provided (scale bar represents 60 mm). The Control 3 sections were
stained by immunofluorescence and all nuclei are red, whereas melanopsin is green (scale bar represents 50 mm). Single to multilayered
RGCs are shown in these pictures. In the lower line, examples of brown-stained mRGCs located in the RGC layer in all three optic
Continued
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explaining the higher incidence of circadian rhythm disorders, such
as sleep disturbances in elderly persons. The current results provide
a plausible explanation for the relatively preserved pupillary light
reaction despite profound visual loss in these patients, revealing
the robustness of mRGCs to a metabolic insult and opening the
question of mechanisms that might protect these cells.
Our study stems from a few reports in the literature showing
that patients with optic neuropathy may maintain the
light-induced melatonin suppression response at night, including
two DOA subjects (Czeisler et al., 1995; Hatonen et al., 1998;
Perez-Rico et al., 2009). In contradistinction, a study of patients
with various optic neuropathies reported the frequent occurrence
of sleep timing disorders, which may indicate a defective photo-
entrainment of circadian rhythms (Wee and Van Gelder, 2004). In
our study, the mitochondrial optic neuropathy subjects, who were
homogeneous for pathology, had no differences compared with
controls in terms of melatonin suppression even if with larger vari-
ability. Remarkably, the maintenance of light-induced melatonin
suppression was unrelated to the severity of the optic neuropathy
in these patients, strongly suggesting that despite the dramatic
loss of total RGCs, the mRGCs were still able to convey light
information to the pineal gland through the retinohypothalamic
tract. It is worth noting that optic neuropathy subjects showed
higher melatonin levels during the baseline night than controls;
this may indicate a certain rearrangement of melatonin secretion
induced by changes in the pattern of light input because of RGC
loss (Lubkin et al., 2002).
To corroborate these results, we studied post-mortem human
retinas from patients with optic neuropathy and controls. We first
characterized the mRGC system in normal human retinas using
sagittal sections from standard paraffin embedded eyes, having
validated a protocol for cell counting in serial sections stained
with melanopsin antibodies. Using this approach, we reached re-
sults strikingly similar to previous estimates of mRGCs in
flat-mounted human retinas, showing that in middle-aged
normal people mRGCs represent 1% of total RGCs, approxi-
mately equally distributed in RGC layer and inner nuclear layer
(Hannibal et al., 2004). Furthermore, we report here the first
evaluation of aging on mRGCs in humans, demonstrating that
after age of 80 there is a reduction of mRGCs, which is about
the same rate as the general reduction of RGCs. This observation
is concordant with previous reports on the age-related decrease of
mRGCs in animal models (Semo et al., 2003). A further finding of
our study was that mRGCs are more concentrated in the parafo-
veal region, as previously reported (Dacey et al., 2005; Jusuf
et al., 2007). A second peak of mRGC numbers was observed
at the far end of the nasal hemiretina, which was not previously
documented in human retinas. It is tempting to speculate that for
non-image-forming and time-integrated functions, the far nasal
retina is well positioned to see the temporal peripheral field,
where the background illumination can be observed rather than
the foreground. However, in animals, different patterns of mRGC
distribution have been found (Hattar et al., 2002; Semo et al.,
2005).
The analysis of pathological retinas from patients with mito-
chondrial optic neuropathy revealed a relative sparing of
mRGCs, as shown by the increase of their ratio over total RGCs
from 1% in controls up to 49% in the most severe case. These
cells were clearly present in the retinal regions most severely
depleted by neurodegeneration, such as the parafoveal area,
which generates the papillomacular bundle (Sadun et al., 2000).
In terms of absolute numbers, mRGCs are reduced to about half in
the LHON cases compared with controls. In the case of the DOA
subject the absolute number of mRGCs was about equal to the
control. This may be explained by the age-related reduction of
mRGCs seen in combination with the neurodegenerative cell loss
in the DOA case.
Our results show that mRGCs are lost in patients with LHON
and DOA but at a much slower rate compared with the regular
RGCs. In fact, this loss does not result in a defective light-induced
suppression of melatonin secretion, which indicates a sufficient
preservation of the retinohypothalamic tract. This observation in
living patients is consistent with a recently published study, which
reported that it requires 80% loss of mRGCs to manifest
Figure 4 Continued
neuropathy subjects are shown (scale bar represents 60mm). Their persistence is remarkable despite the complete absence of the other
RGCs. The DOA sections were stained by immunofluorescence and all nuclei are red, whereas melanopsin is green (scale bar represents
25 mm). (B) Axonal (RGCs) and mRGC count, and mRGC/RGC ratio for control, LHON and DOA subjects. On left, histograms of
axonal counts for averaged Controls 1 and 2, mild LHON (mLHON), severe LHON (sLHON), Control 3 and DOA subjects are shown
demonstrating a severe loss of axons in optic neuropathy subjects. In the middle, histograms of mRGC counts for averaged Controls 1 and
2, mild LHON, severe LHON, Control 3 and DOA subjects are shown revealing a relative preservation of mRGCs in the optic neuropathy
subjects as compared with the severe rate of axonal loss, which equals total RGCs. On the right, the ratio of mRGCs relative to the total
number of RGCs is shown for averaged Controls 1 and 2, and Control 3 (upper line), and for mild LHON, severe LHON and DOA subjects
(lower line). In the optic neuropathy subjects there is a striking increase in the rate of mRGCs, which is inversely correlated with the severity
of RGC loss, indicating their relative preservation. (C) Retinal distribution of mRGCs in subjects with optic neuropathy. Distributions of
mRGCs in four eyes from averaged mild LHON and severe LHON (left) and one eye from DOA (right) are shown. The mean number of
mRGCs (SD) is reported for each 20sector of temporal and nasal hemiretinas, centred on the fovea. Mean number of mRGCs in
parafoveal sector (t10n10) is greater in the two LHON subjects, being significantly different compared with the sectors t60t50,
t50t30 and n50n70 (P= 0.002, 0.04 and 0.008, respectively). In the DOA case the number of mRGCs is uniformly distributed,
lacking a parafoveal peak. (D) Overall retinal distribution of mRGCs in control and optic neuropathy subjects. The distribution of mRGCs
for each eye of Controls 1–3 and for mild LHON, severe LHON and DOA cases are shown. The relative size of the black circles represent
the number of mRGCs for each 5 sector (the x-axis shows the fovea as point 0 and the other sectors as relative to the centre, being
negative for the temporal hemiretina and positive for the nasal hemiretina). In the last line the cumulative distribution of mRGCs is
reported for all controls, all optic neuropathy subjects and merged for everybody. OD = oculus destrum; OS = oculus sinistrum.
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abnormal non-image-forming visual responses in a mouse model
with targeted destruction of mRGCs (Goz et al., 2008). Similarly,
the observed sparing of mRGCs would explain the relative main-
tenance of pupillary light reflex despite profound visual impair-
ment in LHON and DOA (Bremner et al., 1999, 2001). We
have previously shown, in a post-mortem study of a single
LHON case with an extremely severe optic atrophy (Sadun
et al., 2000), spared axons leaving the optic chiasm and projecting
to the pretectum that constitute the afferent arm of the pupillary
light reflex (Bose et al., 2005). Furthermore, we also showed,
using selective wavelength pupillometry, that the pupil contraction
amplitude to blue light, which specifically stimulates mRGCs, was
minimally reduced in the only affected eye in a unilateral case of
LHON (Kawasaki et al., 2010).
Although the current study is the most extensive in human sub-
jects to date, the number of investigated cases is still limited, es-
pecially the post-mortem histopathology of DOA (Kjer et al.,
1983). Thus, for DOA our conclusions are not as firm as they
are for LHON. Indeed, an abnormal masking response on the cir-
cadian running wheel was reported in an OPA1 mouse model of
DOA (Davies et al., 2007). However, the testing paradigm and
the limited loss of RGCs found in this mouse make comparison
between our results and these observations difficult. Our results
on the single DOA case show partial sparing of mRGCs similar to
LHON subjects, yet further investigations are needed to resolve
these issues.
The present study reveals a robustness of mRGCs despite mito-
chondrial dysfunction and leads to the question of which mech-
anisms underlie this resistance to neurodegeneration. There is a
previous body of evidence that supports the current findings.
Remarkably, an old study of RGC loss after optic nerve transection
showed that a small subset (1%) of cells with large bodies, in-
tensively stained with cytochrome c oxidase (complex IV), survived
retrograde cell death (von Bussmann et al., 1993). It is tempting
to speculate that these spared cells, with high mitochondrial
activity as shown by the intense cytochrome c oxidase staining,
were mRGCs. In fact, mRGCs were shown to be partially spared in
a more recent experimental model of axotomy (Robinson and
Madison, 2004). Studies of mRGCs in animal models of glaucoma
with high intraocular pressure have also shown mRGC survival
(Li et al., 2006). A further evidence of mRGC robustness comes
from studies on cell toxicity to monosodium glutamate, showing
that despite severe loss of RGCs, the mRGCs remain and are
functional (Chambille and Serviere, 1993; Hannibal et al., 2001).
We do not presently know if mRGCs present distinctive features
in mitochondrial metabolism compared with the regular RGCs. The
latter are obviously vulnerable to mitochondrial dysfunction, being
the selective target for cell death in mitochondrial optic neuropa-
thies such as LHON and DOA. RGCs have axons that run an
unmyelinated and long stretch in the intraocular retinal nerve
fibre layer. This absence of myelin, necessary for optical transpar-
ency, also imposes a very high energy requirement upon the RGCs
(Carelli et al., 2004). Another hypothesis is that light exposure to
the RGCs and their axons may be directly harmful, especially in
the setting of dysfunctional mitochondria, as in these optic neu-
ropathies (Osborne et al., 2008). It is intriguing to speculate that
mRGCs may be intrinsically protected from light damage by
expressing melanopsin photopigment. Specific investigations are
needed to explore the neuroprotective mechanisms that may pre-
serve mRGCs.
In conclusion, two important implications for medicine are
drawn from our study. Firstly, notwithstanding their low vision,
patients with LHON and DOA have retained the anatomical circuit
supporting the light entrainment of circadian rhythms, thus avoid-
ing consequences of circadian misalignment. Second, elucidating
the distinguishing features of mRGC mitochondrial metabolism will
improve our understanding of intimate pathogenic mechanisms
and provide novel approaches for therapeutic interventions in
these currently untreatable inherited optic neuropathies.
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